A 0 1 0 1 O
pregnancy 2 11 2 11 B-pregnancy
test 12 16 12 16 O
needs 17 22 17 22 O
to 23 25 23 25 O
be 26 28 26 28 O
performed 29 38 29 38 O
within 39 45 39 45 O
72 46 48 46 48 B-upper_bound
hours 49 54 49 54 I-upper_bound
of 55 57 55 57 O
the 58 61 58 61 O
first 62 67 62 67 O
dose 68 72 68 72 O
of 73 75 73 75 O
study 76 81 76 81 B-treatment
drug 82 86 82 86 I-treatment

Absolute 0 8 87 95 B-clinical_variable
neutrophil 9 19 96 106 I-clinical_variable
count 20 25 107 112 I-clinical_variable
( 26 27 113 114 I-clinical_variable
ANC 27 30 114 117 I-clinical_variable
) 30 31 117 118 I-clinical_variable
greater 32 39 119 126 O
than 40 44 127 131 O
or 45 47 132 134 O
equal 48 53 135 140 O
to 54 56 141 143 O
1500 57 61 144 148 B-lower_bound
/ 61 62 148 149 I-lower_bound
mm3 62 65 149 152 I-lower_bound
( 66 67 153 154 O
greater 67 74 154 161 O
than 75 79 162 166 O
or 80 82 167 169 O
equal 83 88 170 175 O
to 89 91 176 178 O
1.5 92 95 179 182 B-lower_bound
X 96 97 183 184 I-lower_bound
103 98 101 185 188 I-lower_bound
/ 101 102 188 189 I-lower_bound
uL 102 104 189 191 I-lower_bound
) 104 105 191 192 O

Active 0 6 193 199 O
hemoptysis 7 17 200 210 B-chronic_disease
( 18 19 211 212 O
bright 19 25 212 218 B-clinical_variable
red 26 29 219 222 I-clinical_variable
blood 30 35 223 228 I-clinical_variable
of 36 38 229 231 O
at 39 41 232 234 O
least 42 47 235 240 O
0.5 48 51 241 244 B-lower_bound
teaspoon 52 60 245 253 I-lower_bound
) 60 61 253 254 O
within 62 68 255 261 O
3 69 70 262 263 B-upper_bound
weeks 71 76 264 269 I-upper_bound
prior 77 82 270 275 I-upper_bound
to 83 85 276 278 O
the 86 89 279 282 O
first 90 95 283 288 O
dose 96 100 289 293 O
of 101 103 294 296 O
study 104 109 297 302 B-treatment
drug 110 114 303 307 I-treatment

Active 0 6 308 314 B-chronic_disease
infection 7 16 315 324 I-chronic_disease
( 17 18 325 326 O
any 18 21 326 329 O
infection 22 31 330 339 O
requiring 32 41 340 349 O
systemic 42 50 350 358 B-treatment
treatment 51 60 359 368 I-treatment
) 60 61 368 369 O

Adequate 0 8 370 378 O
blood 9 14 379 384 O
coagulation 15 26 385 396 O
function 27 35 397 405 O
as 36 38 406 408 O
evidenced 39 48 409 418 O
by 49 51 419 421 O
an 52 54 422 424 O
International 55 68 425 438 B-clinical_variable
Normalized 69 79 439 449 I-clinical_variable
Ratio 80 85 450 455 I-clinical_variable
( 86 87 456 457 I-clinical_variable
INR 87 90 457 460 I-clinical_variable
) 90 91 460 461 I-clinical_variable
less 92 96 462 466 O
than 97 101 467 471 O
or 102 104 472 474 O
equal 105 110 475 480 O
to 111 113 481 483 O
1.5 114 117 484 487 B-upper_bound

Adequate 0 8 488 496 O
liver 9 14 497 502 O
function 15 23 503 511 O
as 24 26 512 514 O
evidenced 27 36 515 524 O
by 37 39 525 527 O
bilirubin 40 49 528 537 B-clinical_variable
less 50 54 538 542 O
than 55 59 543 547 O
or 60 62 548 550 O
equal 63 68 551 556 O
to 69 71 557 559 O
1.5 72 75 560 563 B-upper_bound
times 76 81 564 569 I-upper_bound
the 82 85 570 573 I-upper_bound
ULN 86 89 574 577 I-upper_bound
and 90 93 578 581 O
alkaline 94 102 582 590 B-clinical_variable
phosphatase 103 114 591 602 I-clinical_variable
( 115 116 603 604 I-clinical_variable
ALP 116 119 604 607 I-clinical_variable
) 119 120 607 608 I-clinical_variable
, 120 121 608 609 O
alanine 122 129 610 617 B-clinical_variable
aminotransferase 130 146 618 634 I-clinical_variable
( 147 148 635 636 I-clinical_variable
ALT 148 151 636 639 I-clinical_variable
) 151 152 639 640 I-clinical_variable
, 152 153 640 641 O
and 154 157 642 645 O
aspartate 158 167 646 655 B-clinical_variable
aminotransferase 168 184 656 672 I-clinical_variable
( 185 186 673 674 I-clinical_variable
AST 186 189 674 677 I-clinical_variable
) 189 190 677 678 I-clinical_variable
less 191 195 679 683 O
than 196 200 684 688 O
or 201 203 689 691 O
equal 204 209 692 697 O
to 210 212 698 700 O
3 213 214 701 702 B-upper_bound
X 215 216 703 704 I-upper_bound
ULN 217 220 705 708 I-upper_bound
( 221 222 709 710 O
in 222 224 710 712 O
the 225 228 713 716 O
case 229 233 717 721 O
of 234 236 722 724 O
liver 237 242 725 730 B-clinical_variable
metastases 243 253 731 741 I-clinical_variable
less 254 258 742 746 O
than 259 263 747 751 O
or 264 266 752 754 O
equal 267 272 755 760 O
to 273 275 761 763 O
5 276 277 764 765 B-upper_bound
X 278 279 766 767 I-upper_bound
ULN 280 283 768 771 I-upper_bound
) 283 284 771 772 O

Adequate 0 8 773 781 O
renal 9 14 782 787 O
function 15 23 788 796 O
defined 24 31 797 804 O
as 32 34 805 807 O
creatinine 35 45 808 818 B-clinical_variable
less 46 50 819 823 O
than 51 55 824 828 O
or 56 58 829 831 O
equal 59 64 832 837 O
to 65 67 838 840 O
1.5 68 71 841 844 B-upper_bound
X 72 73 845 846 I-upper_bound
ULN 74 77 847 850 I-upper_bound
( 78 79 851 852 I-upper_bound
upper 79 84 852 857 I-upper_bound
limit 85 90 858 863 I-upper_bound
of 91 93 864 866 I-upper_bound
normal 94 100 867 873 I-upper_bound
) 100 101 873 874 I-upper_bound
or 102 104 875 877 O
calculated 105 115 878 888 B-clinical_variable
creatinine 116 126 889 899 I-clinical_variable
clearance 127 136 900 909 I-clinical_variable
greater 137 144 910 917 O
than 145 149 918 922 O
or 150 152 923 925 O
equal 153 158 926 931 O
to 159 161 932 934 O
40 162 164 935 937 B-lower_bound
mL 165 167 938 940 I-lower_bound
/ 167 168 940 941 I-lower_bound
min 168 171 941 944 I-lower_bound
per 172 175 945 948 O
the 176 179 949 952 O
Cockcroft 180 189 953 962 O
and 190 193 963 966 O
Gault 194 199 967 972 O
formula 200 207 973 980 O
with 208 212 981 985 O
creatinine 213 223 986 996 B-clinical_variable
levels 224 230 997 1003 I-clinical_variable
greater 231 238 1004 1011 O
than 239 243 1012 1016 O
1.5 244 247 1017 1020 O
X 248 249 1021 1022 O
ULN 250 253 1023 1026 O

Adequately 0 10 1027 1037 O
controlled 11 21 1038 1048 O
blood 22 27 1049 1054 B-clinical_variable
pressure 28 36 1055 1063 I-clinical_variable
( 37 38 1064 1065 I-clinical_variable
BP 38 40 1065 1067 I-clinical_variable
) 40 41 1067 1068 I-clinical_variable
with 42 46 1069 1073 O
or 47 49 1074 1076 O
without 50 57 1077 1084 O
antihypertensive 58 74 1085 1101 B-treatment
medications 75 86 1102 1113 I-treatment
, 86 87 1113 1114 O
defined 88 95 1115 1122 O
as 96 98 1123 1125 O
BP 99 101 1126 1128 O
less 102 106 1129 1133 O
than 107 111 1134 1138 O
or 112 114 1139 1141 O
equal 115 120 1142 1147 O
to 121 123 1148 1150 O
150/90 124 130 1151 1157 B-upper_bound
mmHg 131 135 1158 1162 I-upper_bound
at 136 138 1163 1165 O
screening 139 148 1166 1175 O
and 149 152 1176 1179 O
no 153 155 1180 1182 O
change 156 162 1183 1189 O
in 163 165 1190 1192 O
antihypertensive 166 182 1193 1209 O
medications 183 194 1210 1221 O
within 195 201 1222 1228 O
1 202 203 1229 1230 B-upper_bound
week 204 208 1231 1235 I-upper_bound
prior 209 214 1236 1241 I-upper_bound
to 215 217 1242 1244 O
the 218 221 1245 1248 O
Cycle 222 227 1249 1254 O
1 228 229 1255 1256 O
Day 230 233 1257 1260 O
1 234 235 1261 1262 O

All 0 3 1263 1266 O
acute 4 9 1267 1272 B-clinical_variable
toxicities 10 20 1273 1283 I-clinical_variable
related 21 28 1284 1291 O
to 29 31 1292 1294 O
prior 32 37 1295 1300 B-treatment
treatments 38 48 1301 1311 I-treatment
must 49 53 1312 1316 O
be 54 56 1317 1319 O
resolved 57 65 1320 1328 O
to 66 68 1329 1331 O
Grade 69 74 1332 1337 O
less 75 79 1338 1342 O
than 80 84 1343 1347 O
or 85 87 1348 1350 O
equal 88 93 1351 1356 O
to 94 96 1357 1359 O
1 97 98 1360 1361 B-upper_bound

All 0 3 1362 1365 B-gender
females 4 11 1366 1373 I-gender
must 12 16 1374 1378 O
have 17 21 1379 1383 O
a 22 23 1384 1385 O
negative 24 32 1386 1394 B-pregnancy
serum 33 38 1395 1400 I-pregnancy
or 39 41 1401 1403 I-pregnancy
urine 42 47 1404 1409 I-pregnancy
pregnancy 48 57 1410 1419 I-pregnancy
test 58 62 1420 1424 O
( 63 64 1425 1426 O
minimum 64 71 1426 1433 O
sensitivity 72 83 1434 1445 B-clinical_variable
25 84 86 1446 1448 B-lower_bound
IU 87 89 1449 1451 I-lower_bound
/ 89 90 1451 1452 I-lower_bound
L 90 91 1452 1453 I-lower_bound
or 92 94 1454 1456 O
equivalent 95 105 1457 1467 O
units 106 111 1468 1473 O
of 112 114 1474 1476 O
beta 115 119 1477 1481 O
- 119 120 1481 1482 O
human 120 125 1482 1487 O
chorionic 126 135 1488 1497 O
gonadotropin 136 148 1498 1510 O
[ 149 150 1511 1512 O
Î² 150 151 1512 1513 O
- 151 152 1513 1514 O
hCG 152 155 1514 1517 O
] 155 156 1517 1518 O
) 156 157 1518 1519 O
at 158 160 1520 1522 O
the 161 164 1523 1526 O
Screening 165 174 1527 1536 O
Visit 175 180 1537 1542 O
and 181 184 1543 1546 O
the 185 188 1547 1550 O
Baseline 189 197 1551 1559 O
Visit 198 203 1560 1565 O

All 0 3 1566 1569 O
females 4 11 1570 1577 B-gender
will 12 16 1578 1582 O
be 17 19 1583 1585 O
considered 20 30 1586 1596 O
to 31 33 1597 1599 O
be 34 36 1600 1602 O
of 37 39 1603 1605 O
childbearing 40 52 1606 1618 O
potential 53 62 1619 1628 O
unless 63 69 1629 1635 O
they 70 74 1636 1640 O
are 75 78 1641 1644 O
postmenopausal 79 93 1645 1659 O
( 94 95 1660 1661 O
amenorrheic 95 106 1661 1672 O
for 107 110 1673 1676 O
at 111 113 1677 1679 O
least 114 119 1680 1685 O
12 120 122 1686 1688 B-lower_bound
consecutive 123 134 1689 1700 I-lower_bound
months 135 141 1701 1707 I-lower_bound
, 141 142 1707 1708 O
in 143 145 1709 1711 O
the 146 149 1712 1715 O
appropriate 150 161 1716 1727 O
age 162 165 1728 1731 B-age
group 166 171 1732 1737 O
, 171 172 1737 1738 O
and 173 176 1739 1742 O
without 177 184 1743 1750 O
other 185 190 1751 1756 O
known 191 196 1757 1762 O
or 197 199 1763 1765 O
suspected 200 209 1766 1775 O
cause 210 215 1776 1781 O
) 215 216 1781 1782 O
or 217 219 1783 1785 O
have 220 224 1786 1790 O
been 225 229 1791 1795 O
sterilized 230 240 1796 1806 O
surgically 241 251 1807 1817 O
( 252 253 1818 1819 O
ie 253 255 1819 1821 O
, 255 256 1821 1822 O
bilateral 257 266 1823 1832 O
tubal 267 272 1833 1838 O
ligation 273 281 1839 1847 O
, 281 282 1847 1848 O
total 283 288 1849 1854 O
hysterectomy 289 301 1855 1867 O
, 301 302 1867 1868 O
or 303 305 1869 1871 O
bilateral 306 315 1872 1881 O
oophorectomy 316 328 1882 1894 O
, 328 329 1894 1895 O
all 330 333 1896 1899 O
with 334 338 1900 1904 O
surgery 339 346 1905 1912 O
at 347 349 1913 1915 O
least 350 355 1916 1921 O
1 356 357 1922 1923 B-lower_bound
month 358 363 1924 1929 I-lower_bound
before 364 370 1930 1936 O
dosing 371 377 1937 1943 O
) 377 378 1943 1944 O

Archival 0 8 1945 1953 O
tumor 9 14 1954 1959 B-cancer
tissue 15 21 1960 1966 O
or 22 24 1967 1969 O
a 25 26 1970 1971 O
newly 27 32 1972 1977 O
obtained 33 41 1978 1986 O
biopsy 42 48 1987 1993 O
must 49 53 1994 1998 O
be 54 56 1999 2001 O
available 57 66 2002 2011 O
prior 67 72 2012 2017 O
to 73 75 2018 2020 O
the 76 79 2021 2024 O
first 80 85 2025 2030 O
dose 86 90 2031 2035 O
of 91 93 2036 2038 O
study 94 99 2039 2044 B-treatment
drug 100 104 2045 2049 I-treatment
for 105 108 2050 2053 O
biomarker 109 118 2054 2063 O
analysis 119 127 2064 2072 O

Biologic 0 8 2073 2081 B-treatment
response 9 17 2082 2090 I-treatment
modifiers 18 27 2091 2100 I-treatment
( 28 29 2101 2102 O
eg 29 31 2102 2104 O
, 31 32 2104 2105 O
granulocyte 33 44 2106 2117 B-treatment
colony 45 51 2118 2124 I-treatment
- 51 52 2124 2125 I-treatment
stimulating 52 63 2125 2136 I-treatment
factor 64 70 2137 2143 I-treatment
) 70 71 2143 2144 O
within 72 78 2145 2151 O
4 79 80 2152 2153 B-upper_bound
weeks 81 86 2154 2159 I-upper_bound
before 87 93 2160 2166 I-upper_bound
study 94 99 2167 2172 O
entry 100 105 2173 2178 O

Chronic 0 7 2179 2186 O
erythropoietin 8 22 2187 2201 B-treatment
therapy 23 30 2202 2209 I-treatment
is 31 33 2210 2212 O
permitted 34 43 2213 2222 O
provided 44 52 2223 2231 O
that 53 57 2232 2236 O
no 58 60 2237 2239 O
dose 61 65 2240 2244 O
adjustments 66 77 2245 2256 O
were 78 82 2257 2261 O
made 83 87 2262 2266 O
within 88 94 2267 2273 O
2 95 96 2274 2275 B-upper_bound
months 97 103 2276 2282 I-upper_bound
before 104 110 2283 2289 I-upper_bound
first 111 116 2290 2295 B-treatment
dose 117 121 2296 2300 I-treatment
of 122 124 2301 2303 I-treatment
study 125 130 2304 2309 I-treatment
treatment 131 140 2310 2319 I-treatment

Excluding 0 9 2320 2329 O
the 10 13 2330 2333 O
primary 14 21 2334 2341 B-cancer
tumor 22 27 2342 2347 I-cancer
leading 28 35 2348 2355 O
to 36 38 2356 2358 O
enrollment 39 49 2359 2369 O
in 50 52 2370 2372 O
this 53 57 2373 2377 O
study 58 63 2378 2383 O
, 63 64 2383 2384 O
any 65 68 2385 2388 O
other 69 74 2389 2394 O
active 75 81 2395 2401 O
malignancy 82 92 2402 2412 B-cancer
( 93 94 2413 2414 O
except 94 100 2414 2420 O
for 101 104 2421 2424 O
definitively 105 117 2425 2437 O
treated 118 125 2438 2445 O
melanoma 126 134 2446 2454 B-cancer
in 135 137 2455 2457 I-cancer
- 137 138 2457 2458 I-cancer
situ 138 142 2458 2462 I-cancer
, 142 143 2462 2463 O
basal 144 149 2464 2469 B-cancer
or 150 152 2470 2472 O
squamous 153 161 2473 2481 B-cancer
cell 162 166 2482 2486 I-cancer
carcinoma 167 176 2487 2496 I-cancer
of 177 179 2497 2499 I-cancer
the 180 183 2500 2503 I-cancer
skin 184 188 2504 2508 I-cancer
, 188 189 2508 2509 O
or 190 192 2510 2512 O
carcinoma 193 202 2513 2522 B-cancer
in 203 205 2523 2525 I-cancer
- 205 206 2525 2526 I-cancer
situ 206 210 2526 2530 I-cancer
of 211 213 2531 2533 I-cancer
the 214 217 2534 2537 I-cancer
bladder 218 225 2538 2545 I-cancer
or 226 228 2546 2548 I-cancer
cervix 229 235 2549 2555 I-cancer
) 235 236 2555 2556 O
within 237 243 2557 2563 O
the 244 247 2564 2567 O
past 248 252 2568 2572 B-upper_bound
24 253 255 2573 2575 I-upper_bound
months 256 262 2576 2582 I-upper_bound

Females 0 7 2583 2590 B-gender
of 8 10 2591 2593 O
childbearing 11 23 2594 2606 O
potential 24 33 2607 2616 O
must 34 38 2617 2621 O
agree 39 44 2622 2627 B-contraception_consent
to 45 47 2628 2630 I-contraception_consent
use 48 51 2631 2634 I-contraception_consent
a 52 53 2635 2636 I-contraception_consent
highly 54 60 2637 2643 I-contraception_consent
effective 61 70 2644 2653 I-contraception_consent
method 71 77 2654 2660 I-contraception_consent
of 78 80 2661 2663 I-contraception_consent
contraception 81 94 2664 2677 I-contraception_consent
for 95 98 2678 2681 O
the 99 102 2682 2685 O
entire 103 109 2686 2692 O
study 110 115 2693 2698 O
period 116 122 2699 2705 O
and 123 126 2706 2709 O
for 127 130 2710 2713 O
120 131 134 2714 2717 B-upper_bound
days 135 139 2718 2722 I-upper_bound
after 140 145 2723 2728 I-upper_bound
study 146 151 2729 2734 O
discontinuation 152 167 2735 2750 O

Females 0 7 2751 2758 B-gender
who 8 11 2759 2762 O
are 12 15 2763 2766 B-pregnancy
pregnant 16 24 2767 2775 I-pregnancy
or 25 27 2776 2778 O
breastfeeding 28 41 2779 2792 O

For 0 3 2793 2796 O
the 4 7 2797 2800 O
non 8 11 2801 2804 B-chronic_disease
- 11 12 2804 2805 I-chronic_disease
small 12 17 2805 2810 I-chronic_disease
cell 18 22 2811 2815 I-chronic_disease
lung 23 27 2816 2820 I-chronic_disease
cancer 28 34 2821 2827 I-chronic_disease
( 35 36 2828 2829 I-chronic_disease
NSCLC 36 41 2829 2834 I-chronic_disease
) 41 42 2834 2835 I-chronic_disease
and 43 46 2836 2839 O
melanoma 47 55 2840 2848 B-cancer
cohorts 56 63 2849 2856 O
, 63 64 2856 2857 O
participants 65 77 2858 2870 O
must 78 82 2871 2875 O
have 83 87 2876 2880 O
progressed 88 98 2881 2891 O
on 99 101 2892 2894 O
or 102 104 2895 2897 O
after 105 110 2898 2903 O
prior 111 116 2904 2909 B-treatment
treatment 117 126 2910 2919 I-treatment
with 127 131 2920 2924 I-treatment
one 132 135 2925 2928 I-treatment
anti 136 140 2929 2933 I-treatment
- 140 141 2933 2934 I-treatment
PD-1 141 145 2934 2938 I-treatment
, 145 146 2938 2939 O
anti 147 151 2940 2944 B-treatment
- 151 152 2944 2945 I-treatment
PD 152 154 2945 2947 I-treatment
- 154 155 2947 2948 I-treatment
L1 155 157 2948 2950 I-treatment
, 157 158 2950 2951 O
or 159 161 2952 2954 O
anti 162 166 2955 2959 B-treatment
- 166 167 2959 2960 I-treatment
PDL2 167 171 2960 2964 I-treatment
agent 172 177 2965 2970 I-treatment

For 0 3 2971 2974 O
the 4 7 2975 2978 O
renal 8 13 2979 2984 B-cancer
cell 14 18 2985 2989 I-cancer
carcinoma 19 28 2990 2999 I-cancer
( 29 30 3000 3001 I-cancer
RCC 30 33 3001 3004 I-cancer
) 33 34 3004 3005 I-cancer
cohort 35 41 3006 3012 O
, 41 42 3012 3013 O
participants 43 55 3014 3026 O
must 56 60 3027 3031 O
have 61 65 3032 3036 O
progressed 66 76 3037 3047 O
on 77 79 3048 3050 O
treatment 80 89 3051 3060 B-treatment
with 90 94 3061 3065 I-treatment
an 95 97 3066 3068 I-treatment
anti- 98 103 3069 3074 I-treatment
programmed 104 114 3075 3085 I-treatment
death 115 120 3086 3091 I-treatment
receptor-1 121 131 3092 3102 I-treatment
/programmed 132 143 3103 3114 I-treatment
death 144 149 3115 3120 I-treatment
receptor 150 158 3121 3129 I-treatment
- 158 159 3129 3130 I-treatment
ligand 159 165 3130 3136 I-treatment
1 166 167 3137 3138 I-treatment
monoclonal 168 178 3139 3149 I-treatment
antibody 179 187 3150 3158 I-treatment
( 188 189 3159 3160 I-treatment
anti 189 193 3160 3164 I-treatment
- 193 194 3164 3165 I-treatment
PD-1 194 198 3165 3169 I-treatment
/ 198 199 3169 3170 I-treatment
PD 199 201 3170 3172 I-treatment
- 201 202 3172 3173 I-treatment
L1 202 204 3173 3175 I-treatment
mAb 205 208 3176 3179 I-treatment
) 208 209 3179 3180 I-treatment
administered 210 222 3181 3193 O
either 223 229 3194 3200 O
as 230 232 3201 3203 O
monotherapy 233 244 3204 3215 B-treatment
, 244 245 3215 3216 O
or 246 248 3217 3219 O
in 249 251 3220 3222 O
combination 252 263 3223 3234 O
with 264 268 3235 3239 O
other 269 274 3240 3245 O
checkpoint 275 285 3246 3256 B-treatment
inhibitors 286 296 3257 3267 I-treatment
or 297 299 3268 3270 O
other 300 305 3271 3276 O
therapies 306 315 3277 3286 B-treatment

Gastrointestinal 0 16 3287 3303 B-chronic_disease
malabsorption 17 30 3304 3317 I-chronic_disease
, 30 31 3317 3318 O
gastrointestinal 32 48 3319 3335 B-chronic_disease
anastomosis 49 60 3336 3347 I-chronic_disease
, 60 61 3347 3348 O
or 62 64 3349 3351 O
any 65 68 3352 3355 O
other 69 74 3356 3361 O
condition 75 84 3362 3371 O
that 85 89 3372 3376 O
might 90 95 3377 3382 O
affect 96 102 3383 3389 O
the 103 106 3390 3393 O
absorption 107 117 3394 3404 O
of 118 120 3405 3407 O
lenvatinib 121 131 3408 3418 B-treatment

Has 0 3 3419 3422 O
a 4 5 3423 3424 O
diagnosis 6 15 3425 3434 O
of 16 18 3435 3437 O
immunodeficiency 19 35 3438 3454 B-chronic_disease
or 36 38 3455 3457 O
is 39 41 3458 3460 O
receiving 42 51 3461 3470 O
systemic 52 60 3471 3479 B-treatment
steroid 61 68 3480 3487 I-treatment
therapy 69 76 3488 3495 I-treatment
or 77 79 3496 3498 O
any 80 83 3499 3502 O
other 84 89 3503 3508 O
form 90 94 3509 3513 O
of 95 97 3514 3516 O
immunosuppressive 98 115 3517 3534 B-treatment
therapy 116 123 3535 3542 I-treatment
within 124 130 3543 3549 O
7 131 132 3550 3551 B-upper_bound
days 133 137 3552 3556 I-upper_bound
prior 138 143 3557 3562 I-upper_bound
to 144 146 3563 3565 O
the 147 150 3566 3569 O
first 151 156 3570 3575 O
dose 157 161 3576 3580 O
of 162 164 3581 3583 O
study 165 170 3584 3589 B-treatment
treatment 171 180 3590 3599 I-treatment

Has 0 3 3600 3603 O
a 4 5 3604 3605 O
history 6 13 3606 3613 O
of 14 16 3614 3616 O
( 17 18 3617 3618 O
non 18 21 3618 3621 O
- 21 22 3621 3622 O
infectious 22 32 3622 3632 O
) 32 33 3632 3633 O
pneumonitis 34 45 3634 3645 B-chronic_disease
that 46 50 3646 3650 O
required 51 59 3651 3659 O
steroids 60 68 3660 3668 B-treatment
or 69 71 3669 3671 O
current 72 79 3672 3679 O
pneumonitis 80 91 3680 3691 O

Has 0 3 3692 3695 O
received 4 12 3696 3704 O
a 13 14 3705 3706 O
live 15 19 3707 3711 B-treatment
- 19 20 3711 3712 I-treatment
virus 20 25 3712 3717 I-treatment
vaccination 26 37 3718 3729 I-treatment
within 38 44 3730 3736 O
30 45 47 3737 3739 B-upper_bound
days 48 52 3740 3744 I-upper_bound
of 53 55 3745 3747 O
planned 56 63 3748 3755 B-treatment
treatment 64 73 3756 3765 I-treatment
start 74 79 3766 3771 O
. 79 80 3771 3772 O
Seasonal 81 89 3773 3781 O
flu 90 93 3782 3785 B-treatment
vaccines 94 102 3786 3794 I-treatment
that 103 107 3795 3799 O
do 108 110 3800 3802 O
not 111 114 3803 3806 O
contain 115 122 3807 3814 O
live 123 127 3815 3819 O
virus 128 133 3820 3825 O
are 134 137 3826 3829 O
permitted 138 147 3830 3839 O

Hemoglobin 0 10 3840 3850 B-clinical_variable
greater 11 18 3851 3858 O
than 19 23 3859 3863 O
or 24 26 3864 3866 O
equal 27 32 3867 3872 O
to 33 35 3873 3875 O
9.0 36 39 3876 3879 B-lower_bound
g 40 41 3880 3881 I-lower_bound
/ 41 42 3881 3882 I-lower_bound
dL 42 44 3882 3884 I-lower_bound

Histologically 0 14 3885 3899 O
and/or 15 21 3900 3906 O
cytologically 22 35 3907 3920 O
confirmed 36 45 3921 3930 O
metastatic 46 56 3931 3941 B-cancer
selected 57 65 3942 3950 O
solid 66 71 3951 3956 B-cancer
tumor 72 77 3957 3962 I-cancer
types 78 83 3963 3968 O
that 84 88 3969 3973 O
have 89 93 3974 3978 O
progressed 94 104 3979 3989 O
after 105 110 3990 3995 O
treatment 111 120 3996 4005 B-treatment
with 121 125 4006 4010 O
approved 126 134 4011 4019 O
therapies 135 144 4020 4029 B-treatment
or 145 147 4030 4032 O
for 148 151 4033 4036 O
which 152 157 4037 4042 O
there 158 163 4043 4048 O
are 164 167 4049 4052 O
no 168 170 4053 4055 O
standard 171 179 4056 4064 O
effective 180 189 4065 4074 O
therapies 190 199 4075 4084 O
available 200 209 4085 4094 O

Histologically 0 14 4095 4109 O
and/or 15 21 4110 4116 O
cytologically 22 35 4117 4130 O
confirmed 36 45 4131 4140 O
metastatic 46 56 4141 4151 O
selected 57 65 4152 4160 O
solid 66 71 4161 4166 B-cancer
tumor 72 77 4167 4172 I-cancer
types 78 83 4173 4178 O
with 84 88 4179 4183 O
0 89 90 4184 4185 B-lower_bound
- 90 91 4185 4186 O
2 91 92 4186 4187 B-upper_bound
prior 93 98 4188 4193 B-treatment
lines 99 104 4194 4199 I-treatment
of 105 107 4200 4202 I-treatment
systemic 108 116 4203 4211 I-treatment
therapy 117 124 4212 4219 I-treatment
( 125 126 4220 4221 O
unless 126 132 4221 4227 O
discussed 133 142 4228 4237 O
with 143 147 4238 4242 O
the 148 151 4243 4246 O
sponsor 152 159 4247 4254 O
) 159 160 4254 4255 O

History 0 7 4256 4263 O
of 8 10 4264 4266 O
organ 11 16 4267 4272 B-treatment
allograft 17 26 4273 4282 I-treatment
( 27 28 4283 4284 O
Participant 28 39 4284 4295 O
has 40 43 4296 4299 O
had 44 47 4300 4303 O
an 48 50 4304 4306 O
allogenic 51 60 4307 4316 B-treatment
tissue 61 67 4317 4323 I-treatment
/ 67 68 4323 4324 O
solid 68 73 4324 4329 B-treatment
organ 74 79 4330 4335 I-treatment
transplant 80 90 4336 4346 I-treatment
) 90 91 4346 4347 O

In 0 2 4348 4350 O
case 3 7 4351 4355 O
ALP 8 11 4356 4359 B-clinical_variable
is 12 14 4360 4362 O
greater 15 22 4363 4370 O
than 23 27 4371 4375 O
3 28 29 4376 4377 B-lower_bound
X 30 31 4378 4379 I-lower_bound
ULN 32 35 4380 4383 I-lower_bound
( 36 37 4384 4385 O
in 37 39 4385 4387 O
the 40 43 4388 4391 O
absence 44 51 4392 4399 O
of 52 54 4400 4402 O
liver 55 60 4403 4408 B-cancer
metastases 61 71 4409 4419 I-cancer
) 71 72 4419 4420 O
or 73 75 4421 4423 O
greater 76 83 4424 4431 O
than 84 88 4432 4436 O
5 89 90 4437 4438 B-lower_bound
X 91 92 4439 4440 I-lower_bound
ULN 93 96 4441 4444 I-lower_bound
( 97 98 4445 4446 O
in 98 100 4446 4448 O
the 101 104 4449 4452 O
presence 105 113 4453 4461 O
of 114 116 4462 4464 O
liver 117 122 4465 4470 O
metastases 123 133 4471 4481 O
) 133 134 4481 4482 O
AND 135 138 4483 4486 O
the 139 142 4487 4490 O
participant 143 154 4491 4502 O
also 155 159 4503 4507 O
is 160 162 4508 4510 O
known 163 168 4511 4516 O
to 169 171 4517 4519 O
have 172 176 4520 4524 O
bone 177 181 4525 4529 B-cancer
metastases 182 192 4530 4540 I-cancer
, 192 193 4540 4541 O
the 194 197 4542 4545 O
liver 198 203 4546 4551 O
specific 204 212 4552 4560 O
ALP 213 216 4561 4564 O
must 217 221 4565 4569 O
be 222 224 4570 4572 O
separated 225 234 4573 4582 O
from 235 239 4583 4587 O
the 240 243 4588 4591 O
total 244 249 4592 4597 O
and 250 253 4598 4601 O
used 254 258 4602 4606 O
to 259 261 4607 4609 O
assess 262 268 4610 4616 O
the 269 272 4617 4620 O
liver 273 278 4621 4626 O
function 279 287 4627 4635 O
instead 288 295 4636 4643 O
of 296 298 4644 4646 O
the 299 302 4647 4650 O
total 303 308 4651 4656 O
ALP 309 312 4657 4660 O

In 0 2 4661 4663 O
the 3 6 4664 4667 O
case 7 11 4668 4672 O
archival 12 20 4673 4681 O
tissue 21 27 4682 4688 O
can 28 31 4689 4692 O
not 31 34 4692 4695 O
be 35 37 4696 4698 O
provided 38 46 4699 4707 O
, 46 47 4707 4708 O
participants 48 60 4709 4721 O
with 61 65 4722 4726 O
inaccessible 66 78 4727 4739 O
tumors 79 85 4740 4746 B-cancer
for 86 89 4747 4750 O
biopsy 90 96 4751 4757 B-treatment
specimens 97 106 4758 4767 O
can 107 110 4768 4771 O
be 111 113 4772 4774 O
enrolled 114 122 4775 4783 O
without 123 130 4784 4791 O
a 131 132 4792 4793 O
biopsy 133 139 4794 4800 O
upon 140 144 4801 4805 O
consultation 145 157 4806 4818 O
and 158 161 4819 4822 O
agreement 162 171 4823 4832 O
by 172 174 4833 4835 O
the 175 178 4836 4839 O
sponsor 179 186 4840 4847 O

Known 0 5 4848 4853 O
intolerance 6 17 4854 4865 O
to 18 20 4866 4868 O
either 21 27 4869 4875 O
of 28 30 4876 4878 O
the 31 34 4879 4882 O
study 35 40 4883 4888 B-treatment
drugs 41 46 4889 4894 I-treatment
( 47 48 4895 4896 O
or 48 50 4896 4898 O
any 51 54 4899 4902 O
of 55 57 4903 4905 O
the 58 61 4906 4909 O
excipients 62 72 4910 4920 O
) 72 73 4920 4921 O

Lesions 0 7 4922 4929 O
that 8 12 4930 4934 O
have 13 17 4935 4939 O
had 18 21 4940 4943 O
external 22 30 4944 4952 B-treatment
beam 31 35 4953 4957 I-treatment
radiotherapy 36 48 4958 4970 I-treatment
( 49 50 4971 4972 I-treatment
EBRT 50 54 4972 4976 I-treatment
) 54 55 4976 4977 I-treatment
or 56 58 4978 4980 O
loco 59 63 4981 4985 B-treatment
- 63 64 4985 4986 I-treatment
regional 64 72 4986 4994 I-treatment
therapies 73 82 4995 5004 I-treatment
such 83 87 5005 5009 O
as 88 90 5010 5012 O
radiofrequency 91 105 5013 5027 B-treatment
( 106 107 5028 5029 I-treatment
RF 107 109 5029 5031 I-treatment
) 109 110 5031 5032 I-treatment
ablation 111 119 5033 5041 I-treatment
must 120 124 5042 5046 O
show 125 129 5047 5051 O
subsequent 130 140 5052 5062 O
evidence 141 149 5063 5071 O
of 150 152 5072 5074 O
substantial 153 164 5075 5086 O
size 165 169 5087 5091 O
increase 170 178 5092 5100 O
to 179 181 5101 5103 O
be 182 184 5104 5106 O
deemed 185 191 5107 5113 O
a 192 193 5114 5115 O
target 194 200 5116 5122 O
lesion 201 207 5123 5129 O

Life 0 4 5130 5134 B-clinical_variable
expectancy 5 15 5135 5145 I-clinical_variable
of 16 18 5146 5148 O
12 19 21 5149 5151 B-lower_bound
weeks 22 27 5152 5157 I-lower_bound
or 28 30 5158 5160 O
more 31 35 5161 5165 O

Males 0 5 5166 5171 B-gender
or 6 8 5172 5174 O
females 9 16 5175 5182 B-gender
age 17 20 5183 5186 B-age
greater 21 28 5187 5194 O
than 29 33 5195 5199 O
or 34 36 5200 5202 O
equal 37 42 5203 5208 O
to 43 45 5209 5211 O
18 46 48 5212 5214 B-lower_bound
years 49 54 5215 5220 I-lower_bound
at 55 57 5221 5223 O
the 58 61 5224 5227 O
time 62 66 5228 5232 O
of 67 69 5233 5235 O
informed 70 78 5236 5244 O
consent 79 86 5245 5252 O

Must 0 4 5253 5257 O
be 5 7 5258 5260 B-contraception_consent
on 8 10 5261 5263 I-contraception_consent
a 11 12 5264 5265 I-contraception_consent
stable 13 19 5266 5272 I-contraception_consent
dose 20 24 5273 5277 I-contraception_consent
of 25 27 5278 5280 I-contraception_consent
the 28 31 5281 5284 I-contraception_consent
same 32 36 5285 5289 I-contraception_consent
oral 37 41 5290 5294 I-contraception_consent
hormonal 42 50 5295 5303 I-contraception_consent
contraceptive 51 64 5304 5317 I-contraception_consent
product 65 72 5318 5325 I-contraception_consent
for 73 76 5326 5329 O
at 77 79 5330 5332 O
least 80 85 5333 5338 O
4 86 87 5339 5340 B-lower_bound
weeks 88 93 5341 5346 I-lower_bound
before 94 100 5347 5353 I-lower_bound
dosing 101 107 5354 5360 O
with 108 112 5361 5365 O
study 113 118 5366 5371 B-treatment
drug 119 123 5372 5376 I-treatment
and 124 127 5377 5380 O
for 128 131 5381 5384 O
the 132 135 5385 5388 O
duration 136 144 5389 5397 O
of 145 147 5398 5400 O
the 148 151 5401 5404 O
study 152 157 5405 5410 O

New 0 3 5411 5414 B-clinical_variable
York 4 8 5415 5419 I-clinical_variable
Heart 9 14 5420 5425 I-clinical_variable
Association 15 26 5426 5437 I-clinical_variable
congestive 27 37 5438 5448 B-chronic_disease
heart 38 43 5449 5454 I-chronic_disease
failure 44 51 5455 5462 I-chronic_disease
of 52 54 5463 5465 O
grade 55 60 5466 5471 B-lower_bound
II 61 63 5472 5474 I-lower_bound
or 64 66 5475 5477 O
above 67 72 5478 5483 O
, 72 73 5483 5484 O
unstable 74 82 5485 5493 B-chronic_disease
angina 83 89 5494 5500 I-chronic_disease
, 89 90 5500 5501 O
myocardial 91 101 5502 5512 B-chronic_disease
infarction 102 112 5513 5523 I-chronic_disease
within 113 119 5524 5530 O
the 120 123 5531 5534 O
past 124 128 5535 5539 B-upper_bound
6 129 130 5540 5541 I-upper_bound
months 131 137 5542 5548 I-upper_bound

No 0 2 5549 5551 O
active 3 9 5552 5558 O
autoimmune 10 20 5559 5569 B-chronic_disease
disease 21 28 5570 5577 I-chronic_disease
that 29 33 5578 5582 O
has 34 37 5583 5586 O
required 38 46 5587 5595 O
systemic 47 55 5596 5604 B-treatment
treatment 56 65 5605 5614 I-treatment
in 66 68 5615 5617 O
past 69 73 5618 5622 B-upper_bound
2 74 75 5623 5624 I-upper_bound
years 76 81 5625 5630 I-upper_bound
( 82 83 5631 5632 O
ie 83 85 5632 5634 O
, 85 86 5634 5635 O
with 87 91 5636 5640 O
use 92 95 5641 5644 O
of 96 98 5645 5647 O
disease 99 106 5648 5655 B-treatment
modifying 107 116 5656 5665 I-treatment
agents 117 123 5666 5672 I-treatment
, 123 124 5672 5673 O
corticosteroids 125 140 5674 5689 B-treatment
or 141 143 5690 5692 O
immunosuppressive 144 161 5693 5710 B-treatment
drugs 162 167 5711 5716 I-treatment
) 167 168 5716 5717 O

Participant 0 11 5718 5729 O
is 12 14 5730 5732 O
known 15 20 5733 5738 O
to 21 23 5739 5741 O
be 24 26 5742 5744 O
positive 27 35 5745 5753 O
for 36 39 5754 5757 O
Human 40 45 5758 5763 B-chronic_disease
Immunodeficiency 46 62 5764 5780 I-chronic_disease
Virus 63 68 5781 5786 I-chronic_disease
( 69 70 5787 5788 I-chronic_disease
HIV 70 73 5788 5791 I-chronic_disease
) 73 74 5791 5792 I-chronic_disease
, 74 75 5792 5793 O
Hepatitis 76 85 5794 5803 B-chronic_disease
B 86 87 5804 5805 I-chronic_disease
, 87 88 5805 5806 O
or 89 91 5807 5809 O
Hepatitis 92 101 5810 5819 B-chronic_disease
C 102 103 5820 5821 I-chronic_disease

Participants 0 12 5822 5834 O
having 13 19 5835 5841 O
greater 20 27 5842 5849 O
than 28 32 5850 5854 O
1 33 34 5855 5856 B-lower_bound
+ 34 35 5856 5857 I-lower_bound
proteinuria 36 47 5858 5869 B-chronic_disease
on 48 50 5870 5872 O
urinalysis 51 61 5873 5883 B-treatment
will 62 66 5884 5888 O
undergo 67 74 5889 5896 O
24 75 77 5897 5899 O
- 77 78 5899 5900 O
h 78 79 5900 5901 O
urine 80 85 5902 5907 O
collection 86 96 5908 5918 O
for 97 100 5919 5922 O
quantitative 101 113 5923 5935 O
assessment 114 124 5936 5946 O
of 125 127 5947 5949 O
proteinuria 128 139 5950 5961 O

Participants 0 12 5962 5974 O
must 13 17 5975 5979 O
have 18 22 5980 5984 O
an 23 25 5985 5987 O
Eastern 26 33 5988 5995 B-clinical_variable
Cooperative 34 45 5996 6007 I-clinical_variable
Oncology 46 54 6008 6016 I-clinical_variable
Group 55 60 6017 6022 I-clinical_variable
( 61 62 6023 6024 I-clinical_variable
ECOG 62 66 6024 6028 I-clinical_variable
) 66 67 6028 6029 I-clinical_variable
Performance 68 79 6030 6041 I-clinical_variable
Status 80 86 6042 6048 I-clinical_variable
of 87 89 6049 6051 O
0 90 91 6052 6053 B-lower_bound
to 92 94 6054 6056 O
1 95 96 6057 6058 B-upper_bound

Participants 0 12 6059 6071 O
must 13 17 6072 6076 O
have 18 22 6077 6081 O
recovered 23 32 6082 6091 O
adequately 33 43 6092 6102 O
from 44 48 6103 6107 O
any 49 52 6108 6111 O
toxicity 53 61 6112 6120 O
and/or 62 68 6121 6127 O
complications 69 82 6128 6141 O
from 83 87 6142 6146 O
major 88 93 6147 6152 B-treatment
surgery 94 101 6153 6160 I-treatment
prior 102 107 6161 6166 O
to 108 110 6167 6169 O
starting 111 119 6170 6178 O
therapy 120 127 6179 6186 B-treatment

Participants 0 12 6187 6199 O
with 13 17 6200 6204 O
urine 18 23 6205 6210 B-clinical_variable
protein 24 31 6211 6218 I-clinical_variable
greater 32 39 6219 6226 O
than 40 44 6227 6231 O
or 45 47 6232 6234 O
equal 48 53 6235 6240 O
to 54 56 6241 6243 O
1 57 58 6244 6245 B-lower_bound
g/24 59 63 6246 6250 I-lower_bound
- 63 64 6250 6251 I-lower_bound
hour 64 68 6251 6255 I-lower_bound
will 69 73 6256 6260 O
be 74 76 6261 6263 O
ineligible 77 87 6264 6274 O

Platelets 0 9 6275 6284 B-clinical_variable
greater 10 17 6285 6292 O
than 18 22 6293 6297 O
or 23 25 6298 6300 O
equal 26 31 6301 6306 O
to 32 34 6307 6309 O
100,000 35 42 6310 6317 B-lower_bound
/ 42 43 6317 6318 I-lower_bound
mm3 43 46 6318 6321 I-lower_bound
( 47 48 6322 6323 O
greater 48 55 6323 6330 O
than 56 60 6331 6335 O
or 61 63 6336 6338 O
equal 64 69 6339 6344 O
to 70 72 6345 6347 O
100 73 76 6348 6351 B-lower_bound
X 77 78 6352 6353 I-lower_bound
109 79 82 6354 6357 I-lower_bound
/ 82 83 6357 6358 I-lower_bound
L 83 84 6358 6359 I-lower_bound
) 84 85 6359 6360 O

Prior 0 5 6361 6366 B-treatment
anticancer 6 16 6367 6377 I-treatment
treatment 17 26 6378 6387 I-treatment
within 27 33 6388 6394 O
28 34 36 6395 6397 B-upper_bound
days 37 41 6398 6402 I-upper_bound
( 42 43 6403 6404 O
or 43 45 6404 6406 O
5 46 47 6407 6408 O
times 48 53 6409 6414 O
the 54 57 6415 6418 O
half 58 62 6419 6423 O
- 62 63 6423 6424 O
life 63 67 6424 6428 O
time 68 72 6429 6433 O
, 72 73 6433 6434 O
whichever 74 83 6435 6444 O
is 84 86 6445 6447 O
shorter 87 94 6448 6455 O
) 94 95 6455 6456 O
or 96 98 6457 6459 O
any 99 102 6460 6463 O
investigational 103 118 6464 6479 B-treatment
agent 119 124 6480 6485 I-treatment
within 125 131 6486 6492 O
30 132 134 6493 6495 B-upper_bound
days 135 139 6496 6500 I-upper_bound
prior 140 145 6501 6506 I-upper_bound
to 146 148 6507 6509 O
the 149 152 6510 6513 O
first 153 158 6514 6519 B-treatment
dose 159 163 6520 6524 I-treatment
of 164 166 6525 6527 I-treatment
study 167 172 6528 6533 I-treatment
drugs 173 178 6534 6539 I-treatment

Prior 0 5 6540 6545 B-treatment
treatment 6 15 6546 6555 I-treatment
with 16 20 6556 6560 I-treatment
lenvatinib 21 31 6561 6571 I-treatment
or 32 34 6572 6574 O
any 35 38 6575 6578 O
PD-1 39 43 6579 6583 B-treatment
, 43 44 6583 6584 O
anti 45 49 6585 6589 B-treatment
- 49 50 6589 6590 I-treatment
PD 50 52 6590 6592 I-treatment
- 52 53 6592 6593 I-treatment
L1 53 55 6593 6595 I-treatment
, 55 56 6595 6596 O
or 57 59 6597 6599 O
anti 60 64 6600 6604 B-treatment
- 64 65 6604 6605 I-treatment
PD 65 67 6605 6607 I-treatment
- 67 68 6607 6608 I-treatment
L2 68 70 6608 6610 I-treatment
agent 71 76 6611 6616 I-treatment
, 76 77 6616 6617 O
excluding 78 87 6618 6627 O
melanoma 88 96 6628 6636 B-cancer
and 97 100 6637 6640 O
NSCLC 101 106 6641 6646 B-cancer
where 107 112 6647 6652 O
prior 113 118 6653 6658 B-treatment
treatment 119 128 6659 6668 I-treatment
with 129 133 6669 6673 I-treatment
one 134 137 6674 6677 I-treatment
PD-1 138 142 6678 6682 I-treatment
, 142 143 6682 6683 O
anti 144 148 6684 6688 O
- 148 149 6688 6689 O
PD 149 151 6689 6691 O
- 151 152 6691 6692 O
L1 152 154 6692 6694 O
, 154 155 6694 6695 O
or 156 158 6696 6698 O
anti 159 163 6699 6703 O
- 163 164 6703 6704 O
PD 164 166 6704 6706 O
- 166 167 6706 6707 O
L2 167 169 6707 6709 O
agent 170 175 6710 6715 O
is 176 178 6716 6718 O
allowed 179 186 6719 6726 O

Prolongation 0 12 6727 6739 O
of 13 15 6740 6742 O
QTc 16 19 6743 6746 B-clinical_variable
interval 20 28 6747 6755 I-clinical_variable
to 29 31 6756 6758 O
greater 32 39 6759 6766 O
than 40 44 6767 6771 O
480 45 48 6772 6775 B-lower_bound
msec 49 53 6776 6780 I-lower_bound

Replacement 0 11 6781 6792 B-treatment
therapy 12 19 6793 6800 I-treatment
( 20 21 6801 6802 O
eg 21 23 6802 6804 O
, 23 24 6804 6805 O
thyroxine 25 34 6806 6815 B-treatment
, 34 35 6815 6816 O
insulin 36 43 6817 6824 B-treatment
, 43 44 6824 6825 O
or 45 47 6826 6828 O
physiologic 48 59 6829 6840 B-treatment
corticosteroid 60 74 6841 6855 I-treatment
replacement 75 86 6856 6867 I-treatment
therapy 87 94 6868 6875 I-treatment
for 95 98 6876 6879 O
adrenal 99 106 6880 6887 B-chronic_disease
or 107 109 6888 6890 O
pituitary 110 119 6891 6900 B-chronic_disease
insufficiency 120 133 6901 6914 I-chronic_disease
, 133 134 6914 6915 O
etc 135 138 6916 6919 O
. 138 139 6919 6920 O
) 139 140 6920 6921 O
is 141 143 6922 6924 O
not 144 147 6925 6928 O
considered 148 158 6929 6939 O
a 159 160 6940 6941 O
form 161 165 6942 6946 O
of 166 168 6947 6949 O
systemic 169 177 6950 6958 B-treatment
treatment 178 187 6959 6968 I-treatment

Serious 0 7 6969 6976 O
nonhealing 8 18 6977 6987 B-chronic_disease
wound 19 24 6988 6993 I-chronic_disease
, 24 25 6993 6994 O
ulcer 26 31 6995 7000 B-chronic_disease
, 31 32 7000 7001 O
or 33 35 7002 7004 O
bone 36 40 7005 7009 O
fracture 41 49 7010 7018 O

The 0 3 7019 7022 O
use 4 7 7023 7026 O
of 8 10 7027 7029 O
physiologic 11 22 7030 7041 O
doses 23 28 7042 7047 O
of 29 31 7048 7050 O
corticosteroids 32 47 7051 7066 B-treatment
( 48 49 7067 7068 O
up 49 51 7068 7070 O
to 52 54 7071 7073 O
7.5mg 55 60 7074 7079 B-upper_bound
/ 60 61 7079 7080 I-upper_bound
d 61 62 7080 7081 I-upper_bound
of 63 65 7082 7084 O
prednisone 66 76 7085 7095 B-treatment
or 77 79 7096 7098 O
equivalent 80 90 7099 7109 O
) 90 91 7109 7110 O
may 92 95 7111 7114 O
be 96 98 7115 7117 O
approved 99 107 7118 7126 O
after 108 113 7127 7132 O
consultation 114 126 7133 7145 O
with 127 131 7146 7150 O
the 132 135 7151 7154 O
sponsor 136 143 7155 7162 O

a 0 1 7163 7164 O
contraceptive 2 15 7165 7178 B-treatment
implant 16 23 7179 7186 I-treatment

an 0 2 7187 7189 O
oral 3 7 7190 7194 B-contraception_consent
contraceptive 8 21 7195 7208 I-contraception_consent
* 21 22 7208 7209 O
* 22 23 7209 7210 O
( 24 25 7211 7212 O
with 25 29 7212 7216 O
additional 30 40 7217 7227 O
barrier 41 48 7228 7235 O
method 49 55 7236 7242 O
) 55 56 7242 7243 O

articipants 0 11 7244 7255 O
with 12 16 7256 7260 O
known 17 22 7261 7266 O
brain 23 28 7267 7272 B-cancer
metastases 29 39 7273 7283 I-cancer
will 40 44 7284 7288 O
be 45 47 7289 7291 O
eligible 48 56 7292 7300 O
if 57 59 7301 7303 O
they 60 64 7304 7308 O
have 65 69 7309 7313 O
completed 70 79 7314 7323 O
the 80 83 7324 7327 O
primary 84 91 7328 7335 B-treatment
brain 92 97 7336 7341 I-treatment
therapy 98 105 7342 7349 I-treatment
( 106 107 7350 7351 O
such 107 111 7351 7355 O
as 112 114 7356 7358 O
whole 115 120 7359 7364 B-treatment
brain 121 126 7365 7370 I-treatment
radiotherapy 127 139 7371 7383 I-treatment
, 139 140 7383 7384 O
stereotactic 141 153 7385 7397 B-treatment
radiosurgery 154 166 7398 7410 I-treatment
or 167 169 7411 7413 O
complete 170 178 7414 7422 O
surgical 179 187 7423 7431 B-treatment
resection 188 197 7432 7441 I-treatment
) 197 198 7441 7442 O
and 199 202 7443 7446 O
if 203 205 7447 7449 O
they 206 210 7450 7454 O
have 211 215 7455 7459 O
remained 216 224 7460 7468 O
clinically 225 235 7469 7479 O
stable 236 242 7480 7486 O
, 242 243 7486 7487 O
asymptomatic 244 256 7488 7500 O
and 257 260 7501 7504 O
off 261 264 7505 7508 O
of 265 267 7509 7511 O
steroids 268 276 7512 7520 B-treatment
for 277 280 7521 7524 O
at 281 283 7525 7527 O
least 284 289 7528 7533 O
28 290 292 7534 7536 B-lower_bound
days 293 297 7537 7541 I-lower_bound
before 298 304 7542 7548 I-lower_bound
starting 305 313 7549 7557 O
study 314 319 7558 7563 B-treatment
treatment 320 329 7564 7573 I-treatment

excluding 0 9 7574 7583 O
RCC 10 13 7584 7587 B-cancer
where 14 19 7588 7593 O
prior 20 25 7594 7599 B-treatment
treatment 26 35 7600 7609 I-treatment
with 36 40 7610 7614 O
one 41 44 7615 7618 O
regimen 45 52 7619 7626 O
containing 53 63 7627 7637 O
an 64 66 7638 7640 O
anti 67 71 7641 7645 O
- 71 72 7645 7646 O
PD-1 72 76 7646 7650 O
/ 76 77 7650 7651 O
PD 77 79 7651 7653 O
- 79 80 7653 7654 O
L1 80 82 7654 7656 O
mAb 83 86 7657 7660 O
is 87 89 7661 7663 O
required 90 98 7664 7672 O

have 0 4 7673 7677 O
a 5 6 7678 7679 O
vasectomized 7 19 7680 7692 O
partner 20 27 7693 7700 O
with 28 32 7701 7705 O
confirmed 33 42 7706 7715 O
azoospermia 43 54 7716 7727 B-chronic_disease

serious 0 7 7728 7735 O
cardiac 8 15 7736 7743 O
arrhythmia 16 26 7744 7754 B-chronic_disease
associated 27 37 7755 7765 O
with 38 42 7766 7770 O
significant 43 54 7771 7782 O
cardiovascular 55 69 7783 7797 B-chronic_disease
impairment 70 80 7798 7808 I-chronic_disease
within 81 87 7809 7815 O
the 88 91 7816 7819 O
past 92 96 7820 7824 B-upper_bound
6 97 98 7825 7826 I-upper_bound
months 99 105 7827 7833 I-upper_bound

treated 0 7 7834 7841 O
melanoma 8 16 7842 7850 B-cancer
in 17 19 7851 7853 I-cancer
- 19 20 7853 7854 I-cancer
situ 20 24 7854 7858 I-cancer
, 24 25 7858 7859 O
basal 26 31 7860 7865 B-cancer
or 32 34 7866 7868 O
squamous 35 43 7869 7877 B-cancer
cell 44 48 7878 7882 I-cancer
carcinoma 49 58 7883 7892 I-cancer
of 59 61 7893 7895 I-cancer
the 62 65 7896 7899 I-cancer
skin 66 70 7900 7904 I-cancer
, 70 71 7904 7905 O
or 72 74 7906 7908 O
carcinoma 75 84 7909 7918 B-cancer
in 85 87 7919 7921 I-cancer
- 87 88 7921 7922 I-cancer
situ 88 92 7922 7926 I-cancer
of 93 95 7927 7929 I-cancer
the 96 99 7930 7933 I-cancer
bladder 100 107 7934 7941 I-cancer
or 108 110 7942 7944 O
cervix 111 117 7945 7951 B-cancer

